STIMIT is Enrolling Patients in Clinical Trial of Noninvasive Diaphragm Neurostimulation Device
26.11.2024
STIMIT AG announced it is enrolling patients in its FDA Investigational Device Exemption (IDE) clinical trial, “STIMIT ACTIVATOR 1 PIVOTAL STUDY,” with world renowned clinical centers, thus pioneering a transformation in ventilation and critical care.